• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨碱性磷酸酶和甲状旁腺激素与透析前及透析患者某些基本生化指标的相关性

Correlation of bone alkaline phosphatase and iPTH with some basic biochemical markers in predialysis and dialysis patients.

作者信息

Milinković Neda L, Majkic-Singh Nada T, Ignjatović Svetlana D, Lezaić Visnja D, Pejanović Svetlana D, Jovanovic Dijana B

机构信息

Center of Medical Biochemistry, Clinical Center of Serbia, Institute of Medical Biochemistry, Pharmaceutical Faculty, University of Belgrade, Serbia.

出版信息

Clin Lab. 2012;58(7-8):747-53.

PMID:22997975
Abstract

BACKGROUND

Bone alkaline phosphatase (BALP) is a direct and independent indicator of impaired bone turnover. We intended to find out whether there are any significant changes in BALP and iPTH levels, in comparison to total Ca, total Mg, inorganic P, total alkaline phosphatase (ALP), and tartrate resistant acid phosphatase (TRAP) in predialysis and dialysis patients.

METHODS

Out of 266 patients investigated, 114 were on continuous ambulatory peritoneal dialysis, 112 were on maintenance haemodialysis, while 40 predialysis patients had end stage renal disease. The parameters were analysed according to the manufacturers' instructions.

RESULTS

Correlations were established for the bone marker concentrations analysed among the studied groups. The largest ranges were determined for BALP and iPTH. Predialysis and dialysis patients showed very low levels of BALP. Dialysis patients had lower levels of iPTH (p < 0.001), while in predialysis patients the levels were significantly higher (p < 0.05) than recommended for low bone turnover, according to K/DOQI.

CONCLUSIONS

The observations made in this study identify BALP as a good indicator of decreased bone turnover in predialysis and dialysis patients. However, in order to reveal a difference between bone activity and the level of parathyroid activity and its effect on bone turnover, it is always necessary to observe both BALP and iPTH levels.

摘要

背景

骨碱性磷酸酶(BALP)是骨转换受损的直接且独立指标。我们旨在探究与透析前及透析患者的总钙、总镁、无机磷、总碱性磷酸酶(ALP)和抗酒石酸酸性磷酸酶(TRAP)相比,BALP和iPTH水平是否有显著变化。

方法

在266例接受调查的患者中,114例接受持续性非卧床腹膜透析,112例接受维持性血液透析,40例透析前患者患有终末期肾病。各项参数均按照制造商的说明进行分析。

结果

在所研究的组间建立了分析的骨标志物浓度之间的相关性。BALP和iPTH的变化范围最大。透析前和透析患者的BALP水平非常低。透析患者的iPTH水平较低(p < 0.001),而根据K/DOQI,透析前患者的iPTH水平显著高于低骨转换推荐水平(p < 0.05)。

结论

本研究中的观察结果表明BALP是透析前和透析患者骨转换降低的良好指标。然而,为了揭示骨活性与甲状旁腺活性水平及其对骨转换的影响之间的差异,始终有必要同时观察BALP和iPTH水平。

相似文献

1
Correlation of bone alkaline phosphatase and iPTH with some basic biochemical markers in predialysis and dialysis patients.骨碱性磷酸酶和甲状旁腺激素与透析前及透析患者某些基本生化指标的相关性
Clin Lab. 2012;58(7-8):747-53.
2
Clinical significance of bone alkaline phosphatase isoforms, including the novel B1x isoform, in mild to moderate chronic kidney disease.骨碱性磷酸酶同工酶(包括新型 B1x 同工酶)在轻度至中度慢性肾脏病中的临床意义。
Nephrol Dial Transplant. 2009 Nov;24(11):3382-9. doi: 10.1093/ndt/gfp300. Epub 2009 Jun 19.
3
Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients--any advantage?血液透析患者中骨碱性磷酸酶与完整甲状旁腺激素相比——有何优势?
Nephron Clin Pract. 2005;101(3):c122-7. doi: 10.1159/000086682. Epub 2005 Jul 5.
4
Correlations and time course of FGF23 and markers of bone metabolism in maintenance hemodialysis patients.维持性血液透析患者中FGF23与骨代谢标志物的相关性及时间进程
Clin Biochem. 2014 Sep;47(13-14):1316-9. doi: 10.1016/j.clinbiochem.2014.06.009. Epub 2014 Jun 21.
5
Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study.
Am J Kidney Dis. 2007 Dec;50(6):1001-8. doi: 10.1053/j.ajkd.2007.09.001.
6
Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms.慢性肾衰竭对骨转换及骨碱性磷酸酶同工酶的影响。
Kidney Int. 2001 Jul;60(1):257-65. doi: 10.1046/j.1523-1755.2001.00794.x.
7
Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease.透析患者中环化酶激活型与环化酶失活型甲状旁腺激素的比例(CAP/CIP):与其他骨病标志物的相关性
Rocz Akad Med Bialymst. 2004;49:190-2.
8
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.透析治疗的慢性肾脏病患者骨转换标志物和骨组织学的诊断准确性。
Am J Kidney Dis. 2016 Apr;67(4):559-66. doi: 10.1053/j.ajkd.2015.06.023. Epub 2015 Aug 25.
9
Relation between 25(OH)-vitamin D deficiency and markers of bone formation and resorption in haemodialysis patients.血液透析患者25(OH)-维生素D缺乏与骨形成及骨吸收标志物的关系
Clin Lab. 2009;55(9-10):333-9.
10
[Bone biomarkers in haemodialysis patients: bone alkaline phosphatase or ß-Crosslaps?].血液透析患者的骨生物标志物:骨碱性磷酸酶还是β-交联C末端肽?
Nephrol Ther. 2013 Jun;9(3):154-9. doi: 10.1016/j.nephro.2013.02.006. Epub 2013 Mar 29.